Aptevo Therapeutics Inc. · FWB:AP82

Aptevo Therapeutics Inc. shareholders

As of Sep 30, 2026, 10 institutions reported holding Aptevo Therapeutics Inc., 9.8% of its shares. Largest: Sabby Management, LLC, Hudson Bay Capital Management LP and Citadel. New holders, exits, insiders and big stakes, each with its filing.

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Sabby Management, LLC233K6.7%US$423KNewNov 13, 2026
Hudson Bay Capital Management LP40,7001.2%US$74,074NewNov 13, 2026
Citadel25,1710.73%US$45,811NewNov 16, 2026
Gsa Capital Partners LLP21,5390.62%US$39,000No changeNov 16, 2026
Vanguard16,8550.49%US$30,676No changeNov 13, 2026
Tower Research Capital LLC (TRC)1,9110.06%US$3,478NewNov 16, 2026
Osaic Holdings, Inc.3600.01%US$664No changeNov 12, 2026
SBI Securities Co., Ltd.105<0.01%US$191−4Oct 21, 2026
Caitong International Asset Management Co., Ltd3<0.01%US$5NewOct 29, 2026
Danske Bank A/S1<0.01%US$2No changeNov 9, 2026

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Extended Market Index Fund12,7130.37%US$56,446No changeJun 30, 2026
Fidelity Extended Market Index Fund8,9010.26%US$43,704+125May 31, 2026
Fidelity Series Total Market Index Fund1,5480.04%US$7,601+681May 31, 2026

Big stakes

HolderStakeSharesDate
NIOWAVE, INC.12.20%152KMay 25, 2026

Aptevo Therapeutics Inc. insider trades